5329672025-01-012025-03-315329672025-03-315329672024-03-315329672024-04-012025-03-315329672025-01-012025-03-31in-capmkt:OtherExpenses1Member5329672024-04-012025-03-31in-capmkt:OtherExpenses1Member5329672025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15329672024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15329672025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15329672024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15329672025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532967KIRIINDUS0INE415I01015KIRI INDUSTRIES LIMITEDMain BoardEquity2024-04-012025-03-312025-05-302025-05-23INRLakhsQuarterlyFourth quarterSingle segmentThe Company operates in a single segment i. e. Dyes, Dyes Intermediates and basic chemicals. As per Ind As 108 - Operating Segments, the Operation of the Company fall under Chemical Business which is considered to constitute as single primary segment.2025-05-3011:00:002025-05-3013:05:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated20502050006173500021119400001314212000178325000-1220840001131510005392830001124350006173480002752670000-6407300000-640730000-2242600019671000-27550000-637975000000-208418000-846393000-8697000-855090000-8463930000-8697000-85509000055629000010-15.37-14.1400-15.37-14.141. The Company operates in a single segment i. e. Dyes, Dyes Intermediates and Basic Chemicals. As per Ind As 108 - Operating Segments, the Operation of the Company fall under Chemical Business which is considered to constitute as single primary segment. <BR> 2. The above results have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereafter. <BR> 3. The above financial results were reviewed by the Audit Committee and thereafter approved by the Board of Directors at their meeting held on May 30, 2025. <BR> 4. Previous period figures have been regrouped and rearranged wherever considered necessary. <BR> 5. The figures of the quarter ended on March 31, 2025 are the balancing figures between audited figures for the full financial year and published year-to-date figures upto the third quarter of the financial year subject to certain adjustment. <BR> 6. For the quarter ended on March 31, 2025, the share of profit of Associates in financial results is provided after reconciliation of Audited Financials of DyStar Global Holdings (Singapore) Pte. Ltd.(DyStar) for 12 Months period ending om December 31 with the unaudited quarterly performance provided by DyStar Management at the end of each quarter. For the quarter ended on March 31, 2025, the adjustment effect on reconciliation amounts to INR (-) 113.65 Crore in Share of Profit/(Loss) of Associates. <BR> 7. In Standalone Financials for Q4FY25 & FY25, other income include dividend income of INR Nil and INR 9,400.00 Lakhs for quarter and year ended March 31, 2025 respectively from Lonsen Kiri Chemical Industries Limited which is JV of the company <BR> 8. During the period, the company adopted equity method of consolidation of financial statements as per Ind AS 28, 110 & 111 as against proportionate consolidation method earlier used for recognition of group interest in joint venture having management control. Accordingly, the effect of such change in presentation of consolidated financial statements (Profit and Loss statements) of earlier periods have been disclosed by the company as under: <BR> Reconciliation of restated items of consolidated statement of profit and loss: (INR in Lakhs) <BR> Particulars For the quarter ended March 31, 2024 For the year period ended March 31, 2024 <BR> As previously reported Adjustment As Restated As previously reported Adjustment As Restated <BR> Total Income 27,488.73 (5,268.88) 22,219.85 95,788.36 (21,267.75) 74,520.61 <BR> Total expenses 28,359.87 (3,532.00) 24,827.87 103,282.25 (19,643.43) 83,638.82 <BR> Profit/(Loss) before tax (871.14) (1,736.88) (2,608.02) (7,493.89) (1,624.32) (9,118.21) <BR> Tax expense 772.02 (483.65) 288.37 1,295.58 (1,283.55) 12.03 <BR> Profit/(Loss) after tax (1,643.16) (1,253.23) (2,896.39) (8,789.47) (340.77) (9,130.24) <BR> Share of Profit/(Loss) of Associates and Joint Venture accounted for using Equity Method 683.05 1,253.24 1,936.29 22,091.59 3,661.58 25,753.17 <BR> Profit/(Loss) after tax and Share in Profit/(Loss) of Associates and Joint Venture (960.11) 0.01 (960.10) 13,302.12 3,320.81 16,622.93 <BR> Other Comprehensive Income (60.11) (4.20) (64.31) (60.11) (4.20) (64.31) <BR> Total Comprehensive Income after tax (1,020.22) (4.19) (1,024.41) 13,242.01 3,316.61 16,558.62 <BR> Earnings per equity share: - - - <BR> (1) Basic (1.97) (0.01) (1.98) 25.55 6.40 31.95 <BR> (2) Diluted (1.97) (0.01) (1.98) 25.55 6.40 31.95 <BR> <BR> (INR in Lakhs) <BR> Particulars For the quarter ended March 31, 2024 <BR> As previously reported Adjustment As Restated <BR> Non-current assets 285,218.07 27,642.24 312,860.31 <BR> Current assets 55,869.52 (32,200.19) 23,669.33 <BR> Total assets 341,087.59 (4,557.95) 336,529.64 <BR> <BR> Equity 281,172.35 (2,800.00) 278,372.35 <BR> Non-current liabilities 3,186.77 (26.39) 3,160.38 <BR> Current liabilities 56,728.47 (1,731.56) 54,996.91 <BR> Total equity and liabilities 341,087.59 (4,557.95) 336,529.64 <BR> <BR> 9. Relevant material information of a major investment in DyStar Group (Company holds 37.57% share holding) for the quarter ended March 31, 2025. <BR> Sr. No Particulars US$ in Mn. INR in Mn. * <BR> 1 Revenue 177.8 15,216.37 <BR> 2 Gross Margin 54.9 4,698.42 <BR> 3 EBIT 23.9 2,045.40 <BR> 4 EAT 23.6 2,019.72 <BR> ( * 1 US$ = 85.5814 INR) <BR> <BR> 2024-04-012025-03-31AuditedConsolidated7400261000114873900085490000004353213000795297000-35414000462137000127102600044528800023643140009655861000-11068610000-1106861000-8197000-14408000-226050000-108425600000037316160002647360000-270662000237669800026473600000-2706620002376698000556290000103191004000044.6142.810044.6142.81Other Expenses617348000Other Expenses23643140008046710000627328000074000217000002807218100010000001932442000169865000210240700021855800013293360004039681100015346100003447125000108654300012547100016400000225807000245647000514699300021027000152721000685535100000472521620005562900003191004000032466330000200003246635000011142617000000113852900012281146000702080000001235135400086916000203913600087855000212699100011290300023268100009595300095560002139000024344580000014785812000472521620001271026000-295512000-220834000041199000-717918000-40373000-2380990000-17111410000-24295600004452880001682000-97040005248000-21625200011138700000114803800000-82201000000-2655670000-2310282000-341714300000021110000-34192540000003364924000000004069666000000000000001021000021376460000001148038000000-8423177000001400263000179333900000001106339900010467740000012703590000-2503000119373650009493400009493400030537000125471000Remeasurements of the defined benefits plans-5797000-5797000Remeasurements of the defined benefits plans-5797000-579700000Exchange differences in translating financial statements of foreign subsidiary-2900000-2900000Exchange differences in translating financial statements of foreign subsidiary-264865000-26486500000-8697000-270662000AuditedtruePramodkumar Dad & Associatestrue2027-05-31